Bacteremia in diabetic ketoacidosis patients: a retrospective cohort study
Not Applicable
- Conditions
- diabetes ketoacidosis
- Registration Number
- JPRN-UMIN000044097
- Lead Sponsor
- Akashi Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Those without demographic data, evidence of ketosis, plasma glucose, bicarbonate, pH or plasma osmolarity.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link bacteremia to diabetic ketoacidosis in the JPRN-UMIN000044097 cohort study?
How does the incidence of bacteremia in JPRN-UMIN000044097 compare to standard-of-care outcomes for DKA patients?
Are there specific biomarkers identified in JPRN-UMIN000044097 that predict bacteremia risk in type 1 diabetes DKA?
What adverse events were observed in JPRN-UMIN000044097 for DKA patients with concurrent bacteremia and how are they managed?
What combination therapies or drugs are being explored alongside bacteremia management in diabetic ketoacidosis research?